David R. Hassman, DO

Chief Scientific Officer
Hassman Research Institute

Poster(s):

• (83) Long-Term Treatment Benefit of BUP-XR for Patients Struggling to Abstain from Opioids
  Saturday, April 2, 2022

  10:00 AM – 11:30 AM ET